Stryker Corporation (SYK): Director sold ~$10.5M
Ronda E Stryker, Director at Stryker Corporation, sold ~$10.5M of Stryker Corporation shares.
- ~$10.5M
- Approx. value · 29K sh @ $364.58
- 3.28M
- Holds after · shares reported
- Traded
- Nov 5, 2024
- Filed
- Nov 7, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 5, 2024 · this disclosureInsiderDirector sold ~$10.5M of SYK shares in the open market
What came next
- Nov 5, 2024Insider · 1 personInsiders: 7 sales (~$74.0M)
- Nov 7, 2024Insider · 1 personInsiders: 3 sales (~$21.1M)
- Nov 15, 2024InsiderOfficer sold ~$201K of SYK shares in the open market
- Jan 15, 2025Congress · 1 personMembers of Congress: 2 purchases
- Jan 31, 2025Insider · 1 personInsiders: 7 sales (~$92.7M)
- Feb 18, 2025InsiderDirector sold ~$942K of SYK shares in the open market
- Feb 25, 2025FDARecall: Otopore Cylinder outer ear wound dressing, Firm Catalog Number 5400-020-000 and Forte Catalog Number 5400-020-000TL
- Feb 25, 2025FDARecall: Nasopore FD fragmentable nasal dressing, Catalog Numbers 5400-020-108 and 5400-020-108ITL
- Feb 25, 2025FDARecall: Otopore Square outer ear wound dressing, Firm Catalog Number 5400-020-100 and Forte Catalog Number 5400-020-100ITL
- Feb 25, 2025FDARecall: Hemopore 8cm nasal/sinus temporary wound dressing, Catalog Numbers 5400-020-208 and 5400-020-208ITL (OUS)
- Feb 25, 2025FDARecall: Hemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208S
- Feb 25, 2025FDARecall: Nasopore Standard 8cm fragmentable nasal dressing, Catalog Numbers 5400-010-008 and 5400-010-008ITL
- Feb 25, 2025FDARecall: Nasopore 4cm Standard 2PK fragmentable nasal dressing, Catalog Number 5400-212-004S and Nasopore 4cm Firm 2PK Catalog Number 5400-222-004S
- Feb 25, 2025FDARecall: Nasopore 8cm fragmentable nasal dressing, Firm Catalog Number 5400-020-008 and Forte Catalog Number 5400-020-008ITL
- Feb 25, 2025FDARecall: Nasopore Standard 4cm fragmentable nasal dressing, Catalog Numbers 5400-010-004 and 5400-010-004ITL
- Feb 25, 2025FDARecall: Nasopore Ex Firm 4cm fragmentable nasal dressing, Catalog Number 5400-030-004 and Nasopore Forte plus 4cm Catalog Number 5400-030-004ITL
- Feb 25, 2025FDARecall: Nasopore Ex Firm 8cm fragmentable nasal dressing, Catalog Number 5400-030-008 and Nasopore Forte plus 8cm Catalog Number 5400-030-008ITL
- Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 14/16mm; Catalog 48019120.
- Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 10/12mm; Catalog 48019100.
- Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 18/20mm; Catalog 48019130.
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Stryker Corporation
For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.
Other recent filings by Ronda E Stryker, Director
- SEC Form 4 at Stryker Corporation (SYK)Nov 9, 2026
- SEC Form 4 at Stryker Corporation (SYK)Nov 9, 2026
- SEC Form 4 at Stryker Corporation (SYK)Nov 9, 2026
- SEC Form 4 at Stryker Corporation (SYK)Nov 9, 2026
- SEC Form 4 at Stryker Corporation (SYK)Nov 9, 2026
The full history of Ronda E Stryker, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Stryker Corporation (SYK) insider traded, and how much?
Ronda E Stryker, Director at Stryker Corporation, sold ~$10.5M of Stryker Corporation shares. 29K shares at $364.58.
When did it happen, and when was it made public?
Traded: Nov 5, 2024. Filed: Nov 7, 2024. That is 2 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Stryker Corporation recently?
For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days. They are listed on the SYK page.
Does this mean SYK stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Stryker Corporation
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
Everything OQRO holds on this company is on its SYK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
